A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH).

[1]  T. Carpenter.  CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  F. Mignone,et al.  Competitive PCR-High Resolution Melting Analysis (C-PCR-HRMA) for large genomic rearrangements (LGRs) detection: A new approach to assess quantitative status of BRCA1 gene in a reference laboratory. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[3]  G. Gambaro,et al.  A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass , 2017, Urolithiasis.

[4]  F. Mignone,et al.  High Resolution Melting Analysis is Very Useful to Identify Breast Cancer Type 1 Susceptibility Protein (BRCA1) c.4964_4982del19 (rs80359876) Founder Calabrian Pathogenic Variant on Peripheral Blood and Buccal Swab DNA , 2017, Molecular Diagnosis & Therapy.

[5]  G. Gambaro,et al.  Tubular and genetic disorders associated with kidney stones , 2017, Urolithiasis.

[6]  Hanlin Gao,et al.  A Young Woman With Recurrent Gestational Hypercalcemia and Acute Pancreatitis Caused by CYP24A1 Deficiency , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  R. Kumar,et al.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment. , 2016, Endocrine reviews.

[8]  G. Ardissino,et al.  Mutational Spectrum of CYP24A1 Gene in a Cohort of Italian Patients with Idiopathic Infantile Hypercalcemia , 2016, Nephron.

[9]  R. Kumar,et al.  Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect , 2016, Osteoporosis International.

[10]  Z. Gucev,et al.  Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[11]  B. Marks,et al.  Idiopathic infantile hypercalcemia: case report and review of the literature , 2016, Journal of pediatric endocrinology & metabolism : JPEM.

[12]  J. Kaufman,et al.  Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study. , 2015, Bone.

[13]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[14]  K. Eckardt,et al.  Discordant Clinical Course of Vitamin-D-Hydroxylase (CYP24A1) Associated Hypercalcemia in Two Adult Brothers With Nephrocalcinosis , 2015, Kidney and Blood Pressure Research.

[15]  J. Bacchetta,et al.  CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait. , 2015, The Journal of clinical endocrinology and metabolism.

[16]  A. Dusso,et al.  The hypercalcaemia of CYP24A1 inactivation: new ways to improve diagnosis and treatment , 2015, Clinical kidney journal.

[17]  R. Quinton,et al.  Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole , 2015, Clinical kidney journal.

[18]  R. Kumar,et al.  A lifetime of hypercalcemia and hypercalciuria, finally explained. , 2014, The Journal of clinical endocrinology and metabolism.

[19]  Glenville Jones,et al.  Cytochrome P450-mediated metabolism of vitamin D , 2014, Journal of Lipid Research.

[20]  N. Hooman.  Bisphosphonates for treatment of severe idiopathic infantile hypercalcemia. , 2013, Iranian journal of kidney diseases.

[21]  E. Holtzman,et al.  Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis. , 2013, The Journal of urology.

[22]  William A Gahl,et al.  1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[23]  Jan-Gowth Chang,et al.  High-resolution melting: applications in genetic disorders. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[24]  R. Arkell,et al.  High Resolution Melt Analysis (HRMA); a Viable Alternative to Agarose Gel Electrophoresis for Mouse Genotyping , 2012, PloS one.

[25]  Glenville Jones,et al.  25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. , 2012, Archives of biochemistry and biophysics.

[26]  E. Capoluongo,et al.  Rapid and simple identification of the commonest glucose-6-phosphate dehydrogenase (G6PD) Italian mutations: from DNA extraction to genotyping. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[27]  Dawn S Milliner,et al.  Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. , 2012, The Journal of clinical endocrinology and metabolism.

[28]  E. Streeten,et al.  CYP24A1 mutations in idiopathic infantile hypercalcemia. , 2011, The New England journal of medicine.

[29]  M. Konrad,et al.  Mutations in CYP24A1 and idiopathic infantile hypercalcemia. , 2011, The New England journal of medicine.

[30]  Carl T Wittwer,et al.  High-resolution DNA melting analysis in clinical research and diagnostics , 2010, Expert review of molecular diagnostics.

[31]  E. Capoluongo,et al.  Rapid UGT1A1 (TA)(n) genotyping by high resolution melting curve analysis for Gilbert's syndrome diagnosis. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[32]  R. Vossen,et al.  High‐Resolution Melting Analysis (HRMA)—More than just sequence variant screening , 2009, Human mutation.

[33]  A. Bereket,et al.  Oral bisphosphonate therapy for vitamin D intoxication of the infant. , 2003, Pediatrics.

[34]  Y. Mizusawa,et al.  Prednisolone and cellulose phosphate treatment in idiopathic infantile hypercalcaemia with nephrocalcinosis , 1996, Journal of Paediatrics and Child Health.

[35]  S. Little,et al.  Amplification‐Refractory Mutation System (ARMS) Analysis of Point Mutations , 1995, Current protocols in human genetics.

[36]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[37]  F. Bienaimé,et al.  Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  Y. Frishberg,et al.  Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake , 2014, Pediatric Nephrology.

[39]  Oliver Hauss,et al.  The protein truncation test in mutation detection and molecular diagnosis. , 2007, Methods in molecular biology.

[40]  L. Lerman,et al.  Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. , 1987, Methods in enzymology.